Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugo Alarcan

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Annales De Biologie Clinique|October 26, 2019
[Thanatobiochemistry: its contribution to the diagnosis of hypothermia fatalities]Guillaume Rousseau, Clotilde Rougé-Maillart, Hugo Alarcan, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 10, 2022
Problematic rise of vitamin B6 supplementation overuse and potential risk to bariatric surgery patientsValentin Bossard, Nicolas Bourmeyster, Sophie Pasini, et al.
Biomolecules|December 23, 2023
Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Amyotrophic Lateral SclerosisCamille Cotet, Hugo Alarcan, Olivier Hérault, et al.
Biochemistry and Biophysics Reports|February 23, 2024
The effect of pH alterations on TDP-43 in a cellular model of amyotrophic lateral sclerosisYara Al Ojaimi, Charlotte Slek, Samira Osman, et al.
Therapie|November 27, 2019
[Pharmacogenetics for patient care in France: A discipline that evolves!]Chantal Barin-Le Guellec, Nicolas Picard, Hugo Alarcan, et al.
International Journal of Molecular Sciences|July 14, 2023
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in PatientsHugo Alarcan, Patrick Vourc'h, Lise Berton, et al.
Journal of Personalized Medicine|July 27, 2022
Taking Advantages of Blood-Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?Hugo Alarcan, Yara Al Ojaimi, Debora Lanznaster, et al.
SLAS Technology|July 31, 2022
Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosisHugo Alarcan, Mélanie Berthet, Laura Suire, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 16, 2022
Specific changes of erythroid regulators and hepcidin in patients infected by SARS-COV-2Jean-Baptiste Delaye, Hugo Alarcan, Nicolas Vallet, et al.
Biomolecules|June 2, 2021
Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral SclerosisHugo Alarcan, Romane Chaumond, Patrick Emond, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Annales De Biologie Clinique|October 26, 2019
[Thanatobiochemistry: its contribution to the diagnosis of hypothermia fatalities]Guillaume Rousseau, Clotilde Rougé-Maillart, Hugo Alarcan, et al.
Nutrition (Burbank, Los Angeles County, Calif.)|July 10, 2022
Problematic rise of vitamin B6 supplementation overuse and potential risk to bariatric surgery patientsValentin Bossard, Nicolas Bourmeyster, Sophie Pasini, et al.
Biomolecules|December 23, 2023
Neutrophil to Lymphocyte Ratio as a Prognostic Marker in Amyotrophic Lateral SclerosisCamille Cotet, Hugo Alarcan, Olivier Hérault, et al.
Biochemistry and Biophysics Reports|February 23, 2024
The effect of pH alterations on TDP-43 in a cellular model of amyotrophic lateral sclerosisYara Al Ojaimi, Charlotte Slek, Samira Osman, et al.
Therapie|November 27, 2019
[Pharmacogenetics for patient care in France: A discipline that evolves!]Chantal Barin-Le Guellec, Nicolas Picard, Hugo Alarcan, et al.
International Journal of Molecular Sciences|July 14, 2023
Implication of Central Nervous System Barrier Impairment in Amyotrophic Lateral Sclerosis: Gender-Related Difference in PatientsHugo Alarcan, Patrick Vourc'h, Lise Berton, et al.
Journal of Personalized Medicine|July 27, 2022
Taking Advantages of Blood-Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?Hugo Alarcan, Yara Al Ojaimi, Debora Lanznaster, et al.
SLAS Technology|July 31, 2022
Inflammatory mediators, lipoproteins and apolipoproteins in early diagnosis of amyotrophic lateral sclerosisHugo Alarcan, Mélanie Berthet, Laura Suire, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|March 16, 2022
Specific changes of erythroid regulators and hepcidin in patients infected by SARS-COV-2Jean-Baptiste Delaye, Hugo Alarcan, Nicolas Vallet, et al.
Biomolecules|June 2, 2021
Some CSF Kynurenine Pathway Intermediates Associated with Disease Evolution in Amyotrophic Lateral SclerosisHugo Alarcan, Romane Chaumond, Patrick Emond, et al.
Pageof 3